Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy

Michael G Nanna; Sean T Chen; Adam J Nelson; Ann Marie Navar; Eric D Peterson

doi:10.1001/jamainternmed.2020.2750

Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy

JAMA Intern Med. 2020 Nov 1;180(11):1531-1533. doi: 10.1001/jamainternmed.2020.2750.

Authors

Michael G Nanna^{1

2}, Sean T Chen², Adam J Nelson¹, Ann Marie Navar^{1

2}, Eric D Peterson^{1

2}

Affiliations

¹ Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
² Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Abstract

This review compares representation of older adults in interventional cardiovascular disease studies in the US before and after implementation of the National Institutes of Health’s Inclusion Across the Lifespan Policy.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Age Factors
Aged
Cardiovascular Diseases / therapy
Health Policy*
Humans
Longevity / physiology*
Patient Selection*

Abstract

Publication types

MeSH terms

Grants and funding